Adlai Nortye Partners with Lilly and Merck KGaA on Phase 1 AN4035 Combination Study

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in the ongoing...

October 16, 2026 | Friday | News
Salvia BioElectronics Begins U.S. Pivotal Trial of MySalvia System for Resistant Migraine

Salvia BioElectronics, a clinical-stage medical device company pioneering a novel neuromodulation therapy for people with resistant migraine, announced tha...

October 16, 2026 | Friday | News
Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in Diabetic Macular Edema

Eclipse Life Sciences, Inc., a privately held clinical-stage biopharmaceutical company developing next-generation therapies for retinal diseases, announced...

October 16, 2026 | Friday | News
Krystal Biotech Reports Early KB113 Responses in Gorlin Syndrome Study

Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113 Substantial regression was observed i...

October 16, 2026 | Friday | News
FDA Grants Second Fast Track Designation to Marengo’s Invikafusp Alfa

New designation expands on first Fast Track Designation in TMB-H colorectal cancer and is supported by monotherapy responses across m...

October 16, 2026 | Friday | News
Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-1153

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjug...

October 15, 2026 | Thursday | News
Vetter Pharma Expands Fill-Finish Capacity to Meet Growing Demand for Injectable Medicines

As demand for injectable therapies grows and manufacturing requirements become more complex, Vetter Pharma is expanding its global fill-finish network to...

October 15, 2026 | Thursday | Interview
Northwestern Medicine Integrates OpenEvidence into Epic for Clinical Teams

Northwestern Medicine, Chicago’s premier integrated academic health system, and OpenEvidence, a leading AI-powered medical search and clinical decisi...

October 14, 2026 | Wednesday | News
GCCL and LabConnect Expand Clinical Trial Collaboration Across APAC and North America

GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho, announced that it signed a Memorandum of Unders...

October 14, 2026 | Wednesday | News
FDA Clears ArkBio’s AK0406 for Phase 2 Influenza Prevention Study

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")  announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new dr...

October 14, 2026 | Wednesday | News
Cardurion Reports Positive Phase 2 Results for Tovinontrine in HFrEF

In Cycle-1REF Phase 2 clinical trial, tovinontrine demonstrated substantial reduction in NT-proBNP, a biomarker for heart failure, in patients with HFrEF o...

October 13, 2026 | Tuesday | News
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing in the US

Biopharma Boardroom speaks with Nadia Aelbrecht, Vice President, Head of Infectious Disease at QIAGEN, about rapid diagnostics, antimicrobial...

October 12, 2026 | Monday | Interview
Alumis Reports 48-Week Phase 3 Data for Envudeucitinib in Plaque Psoriasis

Results build on ONWARD3 highest complete skin clearance (54% PASI 100) at Week 48, reinforcing envudeucitinib’s potential to become a leading oral...

October 12, 2026 | Monday | News
Innovent Reports Phase 3 Success for SYCUME in Inactive Thyroid Eye Disease

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 12, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close